A qualitative study to explore the perspectives of key stakeholders regarding pharmaceutical pictograms in Pakistan
Kanza Arshad1, Muhammad Atif1, Wajiha Razzaq1
1Department of Pharmacy Practice, Faculty of Pharmacy, The Islamia University of Bahawalpur, Bahawalpur, Pakistan.
Background:
This qualitative study in Pakistan aims to gather perspectives from health regulators, pharmaceutical manufacturers, and healthcare professionals regarding the implementation of pharmaceutical pictograms.
Methods:
An exploratory qualitative study design was used to conduct this study across all provinces of Pakistan. The study adopted a constructivist approach to examine stakeholders' subjective interpretations and to ensure methodological transparency, Consolidated Criteria for Reporting Qualitative Research (COREQ) guidelines were used as reporting guidelines. The data were collected from three main groups through in-depth, face-to-face interviews. The study participants were recruited using a purposive convenience sampling technique. Data analysis was conducted using an inductive thematic analysis approach to draw conclusions aligned with the study objectives.
Results:
A total of 57 respondents participated in the study, including 13 doctors, 15 pharmacists, 15 health regulators, and 14 manufacturers. Analysis of the data yielded five themes and sixteen subthemes. The five key themes were extracted including the current status of pharmaceutical pictograms, the impact of pharmaceutical pictograms, the significance of pharmaceutical pictograms on patients and the healthcare system, and challenges in the implementation of pharmaceuticals. The majority of the respondents demonstrated a better understanding of the term 'pharmaceutical pictograms,' but awareness of standardised systems (USP and FIP) was limited. However, several implementation challenges were identified, including a lack of government recognition and policy support, insufficient training and knowledge among healthcare professionals, and financial or resource constraints. Stakeholders emphasised national policy, training, and awareness to integrate pharmaceutical pictograms.
Conclusion:
The key stakeholders strongly favoured the implementation of pharmaceutical pictograms, recognising their potential to enhance patient comprehension, adherence, and overall safety in Pakistan. However, their adoption is limited by insufficient awareness, policy support, and resources. Addressing these challenges through national policies, professional training, and awareness initiatives is essential for the successful adoption of pictograms in the healthcare system.
More Related Videos
Related Concept Videos
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Drug Control Governance: Regulatory Bodies and Their Impact
Drug Regulation
Bioavailability Study Design: Healthy Subjects Versus Patients
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Factors Influencing Drug Absorption: Pharmaceutical Parameters


